Brief: Clearmind Advances Alcoholism Treatment with Positive Data, DSMB Approval, and New Trial Site
01/12/2025 13:58
Dec 1 (Reuters) - Clearmind Medicine Inc CMND.O: CLEARMIND MEDICINE CHARGES FORWARD IN ALCOHOLISM TREATMENT: POSITIVE COHORT DATA, FULL DSMB APPROVAL, AND NEW ELITE SITE JOINS THE CLINICAL TRIAL Source text: ID:nGNX6mBQSP Further company coverage: CMND.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clearmind Medicine
See all newsBrief: Clearmind Advances Dialogue With U.S. Federal Government On Psychedelic Therapies, Submitting Recommendations To FDA
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM